For research use only. Not for therapeutic Use.
GRP-60367(CAT: I015270), a pioneering small-molecule compound, represents a significant advancement in the field of rabies virus (RABV) research. Operating as a potent RABV entry inhibitor, GRP-60367 demonstrates remarkable nanomolar potency against specific RABV strains. This novel agent holds the potential to revolutionize rabies treatment and prevention strategies by inhibiting viral entry and disrupting the early stages of infection. Its precise mechanism of action makes GRP-60367 a promising candidate for combating rabies and addressing its public health impact.
Catalog Number | I015270 |
CAS Number | 1309241-34-6 |
Molecular Formula | C₂₁H₂₇N₃O₂ |
Purity | ≥95% |
Target | RABV |
Reference | [1]. Venice Du Pont, et al. Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor. J Virol. 2020 Jun 16;94(13):e00321-20. |